Sepsiscan – Strategic-Technological Analysis (Latvia)

Sepsiscan is a Latvian deep-tech spin-off that has developed a portable, AI‐driven medical device for early sepsis detection in intensive care units (ICUs). Sepsis is a critical global healthcare challenge – affecting ~49 million people per year and causing nearly 11 million deaths .

Sepsiscan’s non-invasive imaging system analyzes blood microcirculation and oxygen saturation via multispectral camera and machine-learning algorithms, aiming to alert clinicians to nascent sepsis before symptoms become clinically evident . Founded in 2023 as a University of Latvia laboratory spinoff, Sepsiscan exemplifies a European academic innovation pushing into advanced diagnostics.

This analysis answers: What is Sepsiscan's portable AI-driven medical device and how does its non-invasive multispectral imaging of blood microcirculation and oxygen saturation enable early sepsis detection? How does its machine-learning system aim to alert clinicians before symptoms become clinically evident in ICU settings? How does its origin as a 2023 University of Latvia spinoff shape its research base and dual-use potential? What capability gaps, dependencies and strategic indicators characterise this Latvian deep-tech diagnostics firm?